Risk factors of atrial fibrillation include diabetes, obesity and physical inactivity. Positive effects such as decreased atrial fibrillation burden have been reported for atrial fibrillation patients who have participated in lifestyle changing interventions after atrial fibrillation ablation treatment.
Aim
The aim of this study was to assess the evidence on the benefits and harms of lifestyle and risk factor management interventions in patients undergoing atrial fibrillation ablation.
Method
Our systematic review searched MEDLINE, EMBASE, CINAHL, Psychinfo, Web of Science and CENTRAL using key terms related to atrial fibrillation and lifestyle, including interventional trials. The primary outcomes were mortality and serious adverse events. Random effects meta-analyses of outcomes were conducted when appropriate.
Results
Two randomised controlled trials and two non-randomised interventional trials with a total of 498 patients were included. Six primary events were reported for the intervention groups and five events for the control groups (relative risk of 1.03, 95% confidence interval (CI) 0.3 to 3.1, I2 0%, P = 0.537). Effects in favour of the intervention groups were found for atrial fibrillation frequency (0.82 points, 95% CI –1.60 to –0.03, I2 87.3%, P = 0.005), atrial fibrillation duration (–0.76 points, 95% CI –1.64 to 0.12, I2 89.1%, P = 0.002) and body mass index (–5.40 kg/m2, 95% CI 6.22 to –2.57, I2 83.9%, P = 0.013). Risk of bias in the four studies was judged to be low to moderate.
Conclusion
Lifestyle changing interventions seem to have a positive effect on outcomes relevant to patients undergoing atrial fibrillation ablation, but the included studies were small, interventions were inhomogeneous, and the quality of evidence was low to moderate. More studies are warranted.
KirchhofPBenussiSKotechaD, et al.
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Eur Heart J2016;
37: 2893–2962.
2.
PathakRKMiddeldorpMELauDH, et al.
Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol2014;
64: 2222–2231.
3.
KodamaSSaitoKTanakaS, et al.
Alcohol consumption and risk of atrial fibrillation: a meta-analysis. J Am Coll Cardiol2011;
57: 427–436.
4.
PathakRKMiddeldorpMEMeredithM, et al.
Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol2015;
65: 2159–2169.
5.
CalkinsHKuckKHCappatoR, et al.
2012 HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol2012;
33: 171–257. http://dx.doi.org/10.1016/j.hrthm.2011.12.016 (accessed 4 April 2020).
6.
Chung MK, Eckhardt LL, Chen LY, et al. Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association. Circulation 2020; 141: e750–e772.
7.
StewartSBallJHorowitzJD, et al.
Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial. Lancet2015;
385: 775–784.
8.
HendriksJMLVrijhoefHJMCrijnsHJGM, et al.
The effect of a nurse-led integrated chronic care approach on quality of life in patients with atrial fibrillation. Europace2014;
16: 491–499.
9.
Middeldorp ME, Ariyaratnam J, Lau D, et al. Lifestyle modifications for treatment of atrial fibrillation. Heart 2020; 106: 325–332.
10.
HendriksJMLHeidbüchelH.The management of atrial fibrillation: an integrated team approach – insights of the 2016 European Society of Cardiology guidelines for the management of atrial fibrillation for nurses and allied health professionals.Eur J Cardiovasc Nursing 2019; 18: 88–95.
11.
RisomSSLindJMcCabeP, et al.
Patient perspectives of participating in the cardiac CopenHeartRFA rehabilitation program for patients treated with ablation for atrial fibrillation.J Multidiscipl Healthc2018;
11: 167–174.
12.
HiggensJGreenS (eds). Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. 2011; The Cochrane Collaboration. https://handbook-5-1.cochrane.org/.
13.
MoherDLiberatiATetzlaffJ, et al.; PRISMA Group.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.J Clin Epidemiol2009;
62: 1006–1012.
14.
HigginsJSavovicJSterneJAC, et al.
A revised tool to assess risk of bias in randomized trials (RoB 2.0).Cochrane Database Syst Rev2016; 10: 29–31.
15.
SterneJAHernánMAReevesBC, et al.
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ2016;
355: i4919.
16.
Higgens J and Green S (eds). Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration. www.cochrane-www.handbook.org (2011).
17.
RisomSSZwislerADRasmussenTB, et al.
Cardiac rehabilitation versus usual care for patients treated with catheter ablation for atrial fibrillation: results of the randomized CopenHeart RFA trial. Am Heart J2016;
181: 120–129.
18.
BowyerJLTullyPJGanesanAN, et al.
A randomised controlled trial on the effect of nurse-led educational intervention at the time of catheter ablation for atrial fibrillation on quality of life, symptom severity and rehospitalisation.Heart Lung Circ2017;
26: 73–81.
19.
MohantySMohantyPTrivediC, et al.
Impact of weight loss on ablation-outcome in obese patients with long-standing persistent atrial fibrillation. Heart Rhythm2016;
1: S70.
20.
ParseRR.The human becoming school of thought: a perspective for nurses and other health professionals.
Thousand Oaks, CA:
Sage, 1998. 130 pp.
21.
DorianPJungWNewmanD, et al.
The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol2000;
36: 1303–1309.
22.
AbedHSWittertGALeongDP, et al.
Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA2013;
310: 2050–2060.
23.
MillerJDAronisKNChrispinJ, et al.
Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation.J Am Coll Cardiol2015;
66: 2899–2906.
24.
BunchTMayHBairT, et al.
Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation. Circulation2015;
132: no pagination.
25.
MungerMAStoddardGJWennerAR, et al.
Safety of prescribing PDE-5 inhibitors via e-medicine vs traditional medicine. Mayo Clin Proc2008;
83: 890–896.
26.
ChamberlainAMAgarwalSKFolsomAR, et al.
Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study.Heart Rhythm2011;
8: 1160–1166.
27.
SuzukiSSagaraKOtsukaT, et al.
Effects of smoking habit on the prevalence of atrial fibrillation in Japanese patients with special reference to sex differences. Circ J2013;
77: 2948–2953.
28.
HeeringaJKorsJAHofmanA, et al.
Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study.Am Heart J2008;
156: 1163–1169.
29.
Krahn aDManfredaJTateRB, et al.
The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med1995;
98: 476–484.
30.
BenjaminEJLevyDVaziriSM, et al.
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA1994;
271: 840–844.
31.
BenowitzNL.Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med1988;
319: 1318–1330.
32.
The Danish Minestry of Health. Alcohol and health 2008. Rapport, 67 pages.
33.
LaneDAAguinagaLBlomstroem-LundqvistC, et al.
Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoame. Europace2015;
17: 1747–1769.
34.
MalmoVNesBMAmundsenBH, et al.
Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial.Circulation2016;
133: 466–473.
35.
RisomSSZwislerADJohansenPP, et al.
Exercise-based cardiac rehabilitation for adults with atrial fibrillation. Cochrane Database Syst Rev2017; 2.
Sibilitz KL, Berg SK, Rasmussen TB, et al. Cardiac rehabilitation increases physical capacity but not mental health after heart valve surgery: a randomised clinical trial. Heart 2016; 102: 1995–2003.
RitcheyMDMareshSMcNeelyJ, et al.
Tracking cardiac rehabilitation participation and completion among medicare beneficiaries to inform the efforts of a national initiative. Circ Cardiovasc Qual Outcomes2020;
13: e005902.
40.
Del RosarioMBLovellNHFildesJ, et al.
Evaluation of an mHealth-based adjunct to outpatient cardiac rehabilitation.IEEE J Biomed Health Informat2018;
22: 1938–1948.
41.
MolinariECompareAParatiG.Clinical psychology and heart disease. Italy: Springer-Verlag Italia, 2006.
42.
BuselliEFStuartEM.Influence of psychosocial factors and biopsychosocial interventions on outcomes after myocardial infarction. J Cardiovasc Nurs1999;
13: 60–72.
43.
HaywardC.Psychiatric illness and cardiovascular disease risk.Epidemiol Rev1995;
17: 129–138.
44.
KubzanskyLDKawachiIWeissST, et al.
Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence.Ann Behav Med1998;
20: 47–58.
45.
SiroisBCBurgMM.Negative emotion and coronary heart disease. Behav Modif2003;
27: 83–102.
46.
SmartNAKingNLambertJD, et al.
Exercise-based cardiac rehabilitation improves exercise capacity and health-related quality of life in people with atrial fibrillation: a systematic review and meta-analysis of randomised and non-randomised trials. Openheart2018;
5: 1–11.
47.
MalmDFridlundBEkbladH, et al.
Effects of brief mindfulness-based cognitive behavioural therapy on health-related quality of life and sense of coherence in atrial fibrillation patients.Eur J Cardiovasc Nurs2018;
17: 589–597.
48.
FuenzalidaCHernándezGFerroI, et al.
Long-term benefits of education by emergency care nurses at discharge of patients with atrial fibrillation.Int Emerg Nurs2017;
35: 7–12.
49.
GuoYChenYLaneDA, et al.
Mobile health technology for atrial fibrillation management integrating decision support, education, and patient involvement: mAF App Trial. Am J Med2017;
130: 1388–1396.e6.
50.
GallagherCElliottADWongCX, et al.
Integrated care in atrial fibrillation: a systematic review and meta-analysis.Heart2017;
103: 1947–1953.
51.
WoodKABarnesAHPaulS, et al.
Symptom challenges after atrial fibrillation ablation.Heart Lung2017;
46: 425–431.
52.
HarrisonASDohertyP.Does the mode of delivery in cardiac rehabilitation determine the extent of psychosocial health outcomes?Int J Cardiol2018;
255: 136–139.
53.
JanuaryCTWannLSCalkinsH, et al.
2019 AHA/ACC/HRS Focused update of the 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation. Circulation2019;
140: e125.
54.
HendriksJMde WitRCrijnsHJ, et al.
Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation.Eur Heart J2012;
33: 2692–2699.
55.
ElwynGFroschDThomsonR, et al.
Shared decision making: a model for clinical practice.J Gen Intern Med2012;
27: 1361–1367.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
